Journal for ImmunoTherapy of Cancer (Nov 2020)

604 Intravenous CMP-001, a CpG-A Toll-like receptor 9 (TLR9) agonist delivered via a virus-like particle, causes tumor regression in syngeneic Hepa1–6 mouse models of hepatocellular carcinoma

  • Aaron Morris,
  • Arthur Krieg,
  • Evan Walters,
  • Bassel Akache,
  • Michael McCluskie

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0604
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.